Ashibio Inc
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. (NCT07024407) | Ashibio Inc | 2025-05-14 |
| A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP) (NCT06508021) | Ashibio Inc | 2024-10-25 |
Track Ashibio Inc automatically
Every clearance here is in the API, with alerts when new ones post.